Activation of histidine decarboxylase through post-translational cleavage by caspase-9 in a mouse mastocytoma P-815

Kazuyuki Furuta, Kazuhisa Nakayama, Yukihiko Sugimoto, Atsushi Ichikawa, Satoshi Tanaka

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

L-Histidine decarboxylase (HDC) is the rate-limiting enzyme for histamine synthesis in mammals. Although accumulating evidence has indicated the post-translational processing of HDC, it remains unknown what kinds of proteases are involved. We investigated the processing of HDC in a mouse mastocytoma, P-815, using a lentiviral expression system. HDC was expressed as a 74-kDa precursor form, which is cleaved to yield the 55- and 60-kDa forms upon treatment with butyrate. Alanine-scanning mutations revealed that two tandem aspartate residues (Asp517-Asp518, Asp550- Asp551) are critical for the processing. Treatment with butyrate caused an increase in the enzyme activity of the cells expressing the wild type HDC, but not in the cells expressing the processing-incompetent mutant. An increase in histamine synthesis by butyrate was accompanied by formation of the 55- and 60-kDa form of HDC. In addition, the in vitro translated 74-kDa form of HDC was found to undergo a limited cleavage by purified human caspase-9, whereas the alanine-substituted mutants were not. Processing and enzymatic activation of HDC in P-815 cells was enhanced in the presence of a Zn2+ chelator, TPEN. Although treatment with butyrate and TPEN drastically augmented the protease activity of caspase-3, and -9, no apoptotic cell death was observed. Both enzymatic activation and processing of HDC were completely suppressed by a pan-caspase inhibitor, partially but significantly by a specific inhibitor for caspase-9, but not by a caspase-3 inhibitor. These results suggest that, in P-815 cells, histamine synthesis is augmented through the post-translational cleavage of HDC, which is mediated by caspase-9.

Original languageEnglish
Pages (from-to)13438-13446
Number of pages9
JournalJournal of Biological Chemistry
Volume282
Issue number18
DOIs
Publication statusPublished - May 4 2007
Externally publishedYes

Fingerprint

Histidine Decarboxylase
Mastocytoma
Caspase 9
Histidine
Chemical activation
Butyrates
Processing
Histamine
Caspase Inhibitors
Caspase 3
Alanine
Peptide Hydrolases
Cells
Mammals
Enzyme activity
Cell death
Enzymes
Chelating Agents
Aspartic Acid
Cell Death

ASJC Scopus subject areas

  • Biochemistry

Cite this

Activation of histidine decarboxylase through post-translational cleavage by caspase-9 in a mouse mastocytoma P-815. / Furuta, Kazuyuki; Nakayama, Kazuhisa; Sugimoto, Yukihiko; Ichikawa, Atsushi; Tanaka, Satoshi.

In: Journal of Biological Chemistry, Vol. 282, No. 18, 04.05.2007, p. 13438-13446.

Research output: Contribution to journalArticle

Furuta, Kazuyuki ; Nakayama, Kazuhisa ; Sugimoto, Yukihiko ; Ichikawa, Atsushi ; Tanaka, Satoshi. / Activation of histidine decarboxylase through post-translational cleavage by caspase-9 in a mouse mastocytoma P-815. In: Journal of Biological Chemistry. 2007 ; Vol. 282, No. 18. pp. 13438-13446.
@article{be9cfb3a42c747edbcfc228d5c7ea57e,
title = "Activation of histidine decarboxylase through post-translational cleavage by caspase-9 in a mouse mastocytoma P-815",
abstract = "L-Histidine decarboxylase (HDC) is the rate-limiting enzyme for histamine synthesis in mammals. Although accumulating evidence has indicated the post-translational processing of HDC, it remains unknown what kinds of proteases are involved. We investigated the processing of HDC in a mouse mastocytoma, P-815, using a lentiviral expression system. HDC was expressed as a 74-kDa precursor form, which is cleaved to yield the 55- and 60-kDa forms upon treatment with butyrate. Alanine-scanning mutations revealed that two tandem aspartate residues (Asp517-Asp518, Asp550- Asp551) are critical for the processing. Treatment with butyrate caused an increase in the enzyme activity of the cells expressing the wild type HDC, but not in the cells expressing the processing-incompetent mutant. An increase in histamine synthesis by butyrate was accompanied by formation of the 55- and 60-kDa form of HDC. In addition, the in vitro translated 74-kDa form of HDC was found to undergo a limited cleavage by purified human caspase-9, whereas the alanine-substituted mutants were not. Processing and enzymatic activation of HDC in P-815 cells was enhanced in the presence of a Zn2+ chelator, TPEN. Although treatment with butyrate and TPEN drastically augmented the protease activity of caspase-3, and -9, no apoptotic cell death was observed. Both enzymatic activation and processing of HDC were completely suppressed by a pan-caspase inhibitor, partially but significantly by a specific inhibitor for caspase-9, but not by a caspase-3 inhibitor. These results suggest that, in P-815 cells, histamine synthesis is augmented through the post-translational cleavage of HDC, which is mediated by caspase-9.",
author = "Kazuyuki Furuta and Kazuhisa Nakayama and Yukihiko Sugimoto and Atsushi Ichikawa and Satoshi Tanaka",
year = "2007",
month = "5",
day = "4",
doi = "10.1074/jbc.M609943200",
language = "English",
volume = "282",
pages = "13438--13446",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "18",

}

TY - JOUR

T1 - Activation of histidine decarboxylase through post-translational cleavage by caspase-9 in a mouse mastocytoma P-815

AU - Furuta, Kazuyuki

AU - Nakayama, Kazuhisa

AU - Sugimoto, Yukihiko

AU - Ichikawa, Atsushi

AU - Tanaka, Satoshi

PY - 2007/5/4

Y1 - 2007/5/4

N2 - L-Histidine decarboxylase (HDC) is the rate-limiting enzyme for histamine synthesis in mammals. Although accumulating evidence has indicated the post-translational processing of HDC, it remains unknown what kinds of proteases are involved. We investigated the processing of HDC in a mouse mastocytoma, P-815, using a lentiviral expression system. HDC was expressed as a 74-kDa precursor form, which is cleaved to yield the 55- and 60-kDa forms upon treatment with butyrate. Alanine-scanning mutations revealed that two tandem aspartate residues (Asp517-Asp518, Asp550- Asp551) are critical for the processing. Treatment with butyrate caused an increase in the enzyme activity of the cells expressing the wild type HDC, but not in the cells expressing the processing-incompetent mutant. An increase in histamine synthesis by butyrate was accompanied by formation of the 55- and 60-kDa form of HDC. In addition, the in vitro translated 74-kDa form of HDC was found to undergo a limited cleavage by purified human caspase-9, whereas the alanine-substituted mutants were not. Processing and enzymatic activation of HDC in P-815 cells was enhanced in the presence of a Zn2+ chelator, TPEN. Although treatment with butyrate and TPEN drastically augmented the protease activity of caspase-3, and -9, no apoptotic cell death was observed. Both enzymatic activation and processing of HDC were completely suppressed by a pan-caspase inhibitor, partially but significantly by a specific inhibitor for caspase-9, but not by a caspase-3 inhibitor. These results suggest that, in P-815 cells, histamine synthesis is augmented through the post-translational cleavage of HDC, which is mediated by caspase-9.

AB - L-Histidine decarboxylase (HDC) is the rate-limiting enzyme for histamine synthesis in mammals. Although accumulating evidence has indicated the post-translational processing of HDC, it remains unknown what kinds of proteases are involved. We investigated the processing of HDC in a mouse mastocytoma, P-815, using a lentiviral expression system. HDC was expressed as a 74-kDa precursor form, which is cleaved to yield the 55- and 60-kDa forms upon treatment with butyrate. Alanine-scanning mutations revealed that two tandem aspartate residues (Asp517-Asp518, Asp550- Asp551) are critical for the processing. Treatment with butyrate caused an increase in the enzyme activity of the cells expressing the wild type HDC, but not in the cells expressing the processing-incompetent mutant. An increase in histamine synthesis by butyrate was accompanied by formation of the 55- and 60-kDa form of HDC. In addition, the in vitro translated 74-kDa form of HDC was found to undergo a limited cleavage by purified human caspase-9, whereas the alanine-substituted mutants were not. Processing and enzymatic activation of HDC in P-815 cells was enhanced in the presence of a Zn2+ chelator, TPEN. Although treatment with butyrate and TPEN drastically augmented the protease activity of caspase-3, and -9, no apoptotic cell death was observed. Both enzymatic activation and processing of HDC were completely suppressed by a pan-caspase inhibitor, partially but significantly by a specific inhibitor for caspase-9, but not by a caspase-3 inhibitor. These results suggest that, in P-815 cells, histamine synthesis is augmented through the post-translational cleavage of HDC, which is mediated by caspase-9.

UR - http://www.scopus.com/inward/record.url?scp=34250325497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250325497&partnerID=8YFLogxK

U2 - 10.1074/jbc.M609943200

DO - 10.1074/jbc.M609943200

M3 - Article

VL - 282

SP - 13438

EP - 13446

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 18

ER -